The milk protein α-casein functions as a tumor suppressor via activation of STAT1 signaling, effectively preventing breast cancer tumor growth and metastasis

References

• Henderson BE, Powell D, Rosario I, Keys C, Hanisch R, Young M, et al. An epidemiologic study of breast cancer. J Natl Cancer Inst 1974; 53:609 - 14; PMID: 4369771
   PubMed Web of Science ®Google Scholar
• Kelsey JL, Gammon MD. The epidemiology of breast cancer. CA Cancer J Clin 1991; 41:146 - 65; http://dx.doi.org/10.3322/canjclin.41.3.146; PMID: 1902137
   PubMed Web of Science ®Google Scholar
• Britt K, Ashworth A, Smalley M. Pregnancy and the risk of breast cancer. Endocr Relat Cancer 2007; 14:907 - 33; http://dx.doi.org/10.1677/ERC-07-0137; PMID: 18045947
   PubMed Web of Science ®Google Scholar
• Innes KE, Byers TE. First pregnancy characteristics and subsequent breast cancer risk among young women. Int J Cancer 2004; 112:306 - 11; http://dx.doi.org/10.1002/ijc.20402; PMID: 15352044
   PubMed Web of Science ®Google Scholar
• Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993; 15:36 - 47; PMID: 8405211
   PubMed Web of Science ®Google Scholar
• Trichopoulos D, Hsieh CC, MacMahon B, Lin TM, Lowe CR, Mirra AP, et al. Age at any birth and breast cancer risk. Int J Cancer 1983; 31:701 - 4; http://dx.doi.org/10.1002/ijc.2910310604; PMID: 6862681
   PubMed Web of Science ®Google Scholar
• Sotgia F, Casimiro MC, Bonuccelli G, Liu M, Whitaker-Menezes D, Er O, et al. Loss of caveolin-3 induces a lactogenic microenvironment that is protective against mammary tumor formation. Am J Pathol 2009; 174:613 - 29; http://dx.doi.org/10.2353/ajpath.2009.080653; PMID: 19164602
   PubMed Web of Science ®Google Scholar
• Bonuccelli G, Casimiro MC, Sotgia F, Wang C, Liu M, Katiyar S, et al. Caveolin-1 (P132L), a common breast cancer mutation, confers mammary cell invasiveness and defines a novel stem cell/metastasis-associated gene signature. Am J Pathol 2009; 174:1650 - 62; http://dx.doi.org/10.2353/ajpath.2009.080648; PMID: 19395651
   PubMed Web of Science ®Google Scholar
• Borowsky AD, Namba R, Young LJ, Hunter KW, Hodgson JG, Tepper CG, et al. Syngeneic mouse mammary carcinoma cell lines: two closely related cell lines with divergent metastatic behavior. Clin Exp Metastasis 2005; 22:47 - 59; http://dx.doi.org/10.1007/s10585-005-2908-5; PMID: 16132578
   PubMed Web of Science ®Google Scholar
• Namba R, Young LJ, Abbey CK, Kim L, Damonte P, Borowsky AD, et al. Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ. Clin Cancer Res 2006; 12:2613 - 21; http://dx.doi.org/10.1158/1078-0432.CCR-05-2170; PMID: 16638874
   PubMed Web of Science ®Google Scholar
• Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, Old LJ, et al. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci USA 1998; 95:7556 - 61; http://dx.doi.org/10.1073/pnas.95.13.7556; PMID: 9636188
   PubMed Web of Science ®Google Scholar
• Minutilli E, Feliciani C. Adjuvant therapy for resected stage III melanoma patients: high-dose interferon-alpha versus ipilimumab combined with kinases inhibitors. Tumori 2012; 98:185 - 90; PMID: 22677983
   PubMed Web of Science ®Google Scholar
• Simonsson B, Gedde-Dahl T, Markevärn B, Remes K, Stentoft J, Almqvist A, et al, Nordic CML Study Group. Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia. Blood 2011; 118:3228 - 35; http://dx.doi.org/10.1182/blood-2011-02-336685; PMID: 21685374
   PubMed Web of Science ®Google Scholar
• Roberts NJ, Zhou S, Diaz LA Jr., Holdhoff M. Systemic use of tumor necrosis factor alpha as an anticancer agent. Oncotarget 2011; 2:739 - 51; PMID: 22036896
   PubMed Web of Science ®Google Scholar
• Widschwendter A, Tonko-Geymayer S, Welte T, Daxenbichler G, Marth C, Doppler W. Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer. Clin Cancer Res 2002; 8:3065 - 74; PMID: 12374673
   PubMed Web of Science ®Google Scholar
• Klover PJ, Muller WJ, Robinson GW, Pfeiffer RM, Yamaji D, Hennighausen L. Loss of STAT1 from mouse mammary epithelium results in an increased Neu-induced tumor burden. Neoplasia 2010; 12:899 - 905; PMID: 21076615
   PubMed Web of Science ®Google Scholar
• Raven JF, Williams V, Wang S, Tremblay ML, Muller WJ, Durbin JE, et al. Stat1 is a suppressor of ErbB2/Neu-mediated cellular transformation and mouse mammary gland tumor formation. Cell Cycle 2011; 10:794 - 804; http://dx.doi.org/10.4161/cc.10.5.14956; PMID: 21311224
   PubMed Web of Science ®Google Scholar
• Chan SR, Vermi W, Luo J, Lucini L, Rickert C, Fowler AM, et al. STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas. Breast Cancer Res 2012; 14:R16; http://dx.doi.org/10.1186/bcr3100; PMID: 22264274
   PubMed Web of Science ®Google Scholar
• Prinzenberg EM, Weimann C, Brandt H, Bennewitz J, Kalm E, Schwerin M, et al. Polymorphism of the bovine CSN1S1 promoter: linkage mapping, intragenic haplotypes, and effects on milk production traits. J Dairy Sci 2003; 86:2696 - 705; http://dx.doi.org/10.3168/jds.S0022-0302(03)73865-X; PMID: 12939094
   PubMed Web of Science ®Google Scholar
• Ramunno L, Longobardi E, Pappalardo M, Rando A, Di Gregorio P, Cosenza G, et al. An allele associated with a non-detectable amount of alpha s2 casein in goat milk. Anim Genet 2001; 32:19 - 26; http://dx.doi.org/10.1046/j.1365-2052.2001.00710.x; PMID: 11419340
   PubMed Web of Science ®Google Scholar
• Trimmer C, Whitaker-Menezes D, Bonuccelli G, Milliman JN, Daumer KM, Aplin AE, et al. CAV1 inhibits metastatic potential in melanomas through suppression of the integrin/Src/FAK signaling pathway. Cancer Res 2010; 70:7489 - 99; http://dx.doi.org/10.1158/0008-5472.CAN-10-0900; PMID: 20709760
   PubMed Web of Science ®Google Scholar
• Ertel A, Tsirigos A, Whitaker-Menezes D, Birbe RC, Pavlides S, Martinez-Outschoorn UE, et al. Is cancer a metabolic rebellion against host aging? In the quest for immortality, tumor cells try to save themselves by boosting mitochondrial metabolism. Cell Cycle 2012; 11:253 - 63; http://dx.doi.org/10.4161/cc.11.2.19006; PMID: 22234241
   PubMed Web of Science ®Google Scholar
• Edelman E, Porrello A, Guinney J, Balakumaran B, Bild A, Febbo PG, et al. Analysis of sample set enrichment scores: assaying the enrichment of sets of genes for individual samples in genome-wide expression profiles. Bioinformatics 2006; 22:e108 - 16; http://dx.doi.org/10.1093/bioinformatics/btl231; PMID: 16873460
   PubMedGoogle Scholar
• Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100:3983 - 8; http://dx.doi.org/10.1073/pnas.0530291100; PMID: 12629218
   PubMed Web of Science ®Google Scholar
• Jiao X, Katiyar S, Willmarth NE, Liu M, Ma X, Flomenberg N, et al. c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion. J Biol Chem 2010; 285:8218 - 26; http://dx.doi.org/10.1074/jbc.M110.100792; PMID: 20053993
   PubMed Web of Science ®Google Scholar